Notícias e Atividades da scPharmaceuticals

scPharmaceuticals é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

scPharmaceuticals é uma empresa listada sob o símbolo SCPH (US).

Veja o organograma con seus 12 executivos principais

Biografias mais buscadas da scPharmaceuticals

• John Tucker, Director, President and Chief Executive Officer
• Sara Bonstein, Director
• Minnie Baylor-Henry, Director

Criar um alerta
para seguir os movimentos de executivos da scPharmaceuticals.

scPharmaceuticals possui 1.833 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Eli Lilly (Estados Unidos).

Popular M&A news in Farmacêutica

• Imbria Pharmaceuticals acaba de anunciar uma arrecadação de fundos de 58 milhões de dólares. (publicado em 10 de abril de 2025).
• Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).
• Knight Therapeutics has announced the acquisition of Paladin Labs  (publicado em 12 de março de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer da Adare Pharmaceuticals
• Paul Meister - Chairman of the Board da Amneal Pharmaceuticals

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de scPharmaceuticals

• scPharmaceuticals Provides Business Update | scPharmaceuticals, Inc.
• scPharmaceuticals Hosting Key Opinion Leader Call on FUROSCIX® (furosemide) for subcutaneous administration | scPharmaceuticals, Inc.
• scPharmaceuticals to Participate in Two Upcoming Investor Conferences | scPharmaceuticals, Inc.
• scPharmaceuticals Inc. Reports Second Quarter 2020 Financial Results and Provides Business Update | scPharmaceuticals, Inc.
• scPharmaceuticals Announces FDA Acceptance of FUROSCIX® New Drug Application Resubmission | scPharmaceuticals, Inc.
• scPharmaceuticals Appoints Sara Bonstein to Board of Directors | scPharmaceuticals, Inc.
• scPharmaceuticals Announces FUROSCIX® NDA Resubmission | scPharmaceuticals, Inc.
• scPharmaceuticals Announces New Presentation Time for BMO’s Virtual 2020 Prescriptions for Success Healthcare Conference | scPharmaceuticals, Inc.
• scPharmaceuticals Inc. to Present at Upcoming Investor Conferences | scPharmaceuticals, Inc.
• scPharmaceuticals Announces Pricing of Public Offering of Common Stock | scPharmaceuticals, Inc.
• View more press releases Close

Redes sociais sobre scPharmaceuticals

• scPharmaceuticals na Wikipedia, Google News e Yahoo Finance
• scPharmaceuticals na LinkedIn, Twitter e YouTube